Skip to Main Content


1980s - (Fagan) Gray

Yale Medicine Magazine, 2004 - Summer


Mary Ann (Fagan) Gray, Ph.D., FW ’87, owner of Gray Strategic Advisors, which advises public and private biotechnology companies, has joined the board of Dyax Corporation, a company that focuses on antibodies, small proteins and peptides as therapeutic products for unmet medical needs, particularly in the areas of inflammation and oncology.